Past seminars

On the frontline: a clinician's reality of AMR in the UK - 28 April 2025

13:00 - 13:05

Welcome and introduction
Dr Robert Shorten (Consultant Clinical Scientist and Associate Clinical Director of Pathology, Lancashire Teaching Hospitals NHS Foundation Trust) and Dr Sanjay Patel (Consultant in Paediatric Infectious Diseases and Immunology, Southampton Children’s Hospital)

13:05 - 13:15

Case study: Details to follow

13:15 - 13:45

Panel discussion and Q +A:

Dr Robert Shorten (Consultant Clinical Scientist and Associate Clinical Director of Pathology, Lancashire Teaching Hospitals NHS Foundation Trust)<br />
Dr Sanjay Patel (Consultant in Paediatric Infectious Diseases and Immunology, Southampton Children’s Hospital)<br />
Dr Katie Hopkins (Lead Clinical Scientists, UKHSA)<br />
Dr Louise Sweeney (Consultant Clinical Microbiologist, Manchester University NHS Foundation Trust)

What's New In Therapeutics- 27 January 2025

Chair: Prof Chloe James (Chair in Microbiology, University of Salford)

13:00 - 13:05	Welcome and introduction Prof Chloe James (Chair in Microbiology, University of Salford)
13:05 - 13:25	Panel introduction Panellists: Prof Jo Fothergill (Director of Microbiomes Centre, Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool) Prof Shampa Das (Head of Dept of Pharmacology & Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool) Dr Clare Trippett (Principal Strategic Opportunities Manager, CPI) Dr Deborah O’Neil (Chief Executive Officer, NovaBiotics Ltd)
13:25 - 13:45	Panel discussion Panellists
13:45 - 13:55	Q&A session Panellists
13:55 - 14:00	Closing remarks Prof Chloe James (Chair in Microbiology, University of Salford)

What regulators want you to know - 25 November 2024

Chair: Carmen Coxon (Medicines and Healthcare Regulatory Agency, UK)

14:00 - 14:05	Welcome and introduction Carmen Coxon (Medicines and Healthcare Regulatory Agency, UK)
14:05 - 14:10	The role of the MHRA and how we support AMR research and innovation Carmen Coxon (Medicines and Healthcare Regulatory Agency, UK)
14:10 - 14:15	AMR surveillance of the food chain Kathryn Callaghan (Food Standards Agency, UK)
14:15 - 14:25	Health, safety and environmental considerations for AMR product developers Sean Simpkins (Department for Environment Food and Rural Affairs, UK)
14:25 - 14:30	Considering AMR in low- and middle-income countries (LMICs) Sheetal Ghelani (Clinton Health Access Initiative, USA)
14:30 - 14:55	Q&A with panel
14:55 - 15:00	14:55 - 15:00

Opportunities for Diagnostics Research - 22 October 2024

Chair: Tina Joshi, Associate Professor of Molecular Microbiology, Co-Chair of Knocking Out AMR Project

13:00–13:15	PACE: 2024 Diagnostic Innovations funding call Clive Mason, PACE Programme Director, AMR
13:15–13:30	Microplate Dx research Paul Hoskisson, Microplate Dx Chief Scientific Advisor/ University of Strathclyde
13:30–13:45	Research opportunities in AMR Diagnostics Helen Dent, BIVDA
13:45–14:00	Panel Q&A

Engaging with Policymakers on AMR – 16 September 2024

Chair: Emily Hugo-Webb (Policy and Engagement Manager, Microbiology Society)

13:00–13:15	An introduction to engaging with policymakers Emily Hugo-Webb (Policy and Engagement Manager, Microbiology Society)
13:15–13:20	My experience of engaging with policymakers Frances Spragge (Microbiology Society Parliamentary Internship)
13:20–13:25	My experience of engaging with policymakers Frances Spragge (Microbiology Society Parliamentary Internship)
13:25–13:35	Moving from academia to science policy; opinions on future of AMR policy Prof Robin May (Microbiology Society member; Chief Scientific Advisor at the Food Standards Agency)
13:35–13:45	The UK NAP and how to engage with it Connie Longmate (Team lead – IPC and AMR Department of Health and Social Care)
13:45–13:55	UNGA: What it is, how to get involved, what will be discussed AMR Multi-Stakeholder Partnership Platform Representative
13:55–14:00	Closing remarks and call to action Emily Hugo-Webb (Policy and Engagement Manager, Microbiology Society)